Interventional technology firm Medtronic has received U.S. Food and Drug Administration (FDA) clearance for its Complete SE vascular stent system.
Complete SE was cleared for use in treating peripheral arterial disease in the iliac arteries, according to the Minneapolis-based firm.
Related Reading
Medtronic brings SureScan to Europe, March 17, 2010
Medtronic pledges $1M for Haiti relief, January 22, 2010
Medtronic hires new VP, December 3, 2009
Medtronic launches 3D service with Vital, November 19, 2009
Medtronic settles patent dispute, September 17, 2009
Copyright © 2010 AuntMinnie.com